Results for tag: "Lomitapide"

Lomitapide is a cardiovascular drug used to treat homozygous familial hypercholesterolemia (HoFH). It is a microsomal triglyceride transfer protein (MTP) inhibitor, which works by reducing the production of cholesterol in the liver. It is usually prescribed in combination with other lipid-lowering therapies, such as statins and ezetimibe. Lomitapide is available in capsule form and is taken orally. The lomitapide market is a relatively small but growing segment of the cardiovascular drug market. It is mainly used to treat HoFH, a rare genetic disorder that causes high levels of cholesterol in the blood. As the prevalence of HoFH increases, the demand for lomitapide is expected to rise. Additionally, the development of new formulations of lomitapide, such as extended-release tablets, is likely to further drive the market growth. Some of the key players in the lomitapide market include Aegerion Pharmaceuticals, Inc., Amgen Inc., Sanofi, and Pfizer Inc. Show Less Read more